Bhutan vs Chile: Cause of death, by non-communicable diseases, ages 15-59, female
Bhutan
66.5%
in 2021
Chile
66.3%
in 2021
Bhutan rank
73rd
Chile rank
75th
Cause of death, by non-communicable diseases, ages 15-59, female over time
- Bhutan
- Chile
How they compare
Bhutan currently reports 66.5% against 66.3% in Chile, a difference of 0.2%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Chile ahead.
Bhutan ranks 73rd and Chile ranks 75th of 185 countries.
Chile has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bhutan | Chile | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 52.0% | 81.1% | 29.2% | Chile |
| 2010s | 62.4% | 81.5% | 19.1% | Chile |
| 2020s | 66.6% | 69.7% | 3.1% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, female, Bhutan or Chile?
- Bhutan, at 66.5% against 66.3% in Chile as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, female between Bhutan and Chile?
- 0.2%, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and Chile?
- 6 years are reported by both, from 2000 to 2021.
- How do Bhutan and Chile rank globally for cause of death, by non-communicable diseases, ages 15-59, female?
- Bhutan ranks 73rd and Chile ranks 75th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.